Analgesic, sedative, antipsychotic, and neuromuscular blocker use in Canadian intensive care units: a prospective, multicentre, observational study View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2014-05-01

AUTHORS

Lisa D. Burry, David R. Williamson, Marc M. Perreault, Louise Rose, Deborah J. Cook, Niall D. Ferguson, Stephanie C. Lapinsky, Sangheeta Mehta

ABSTRACT

PurposeOur aim was to describe analgo-sedation and antipsychotic and neuromuscular blocking drug (NMBD) use in critically ill patients, management strategies, and variables associated with these practice patterns.MethodsThis prospective observational study in 51 intensive care units (ICUs) included all patients who underwent invasive mechanical ventilation (MV) over a two-week period during 2008-2009.ResultsWe included 712 patients representing 3,620 patient-days. Median MV duration was 3.0 days (interquartile range 2-6). During MV, 92% of patients received analgo-sedation, 32% an adjunct agent (e.g., acetaminophen), 18% NMBDs, and 10% antipsychotics. Opioids were used more frequently than benzodiazepines or propofol (84.8% vs 62.2% vs 10.1% patients, respectively, P < 0.0001). Independent predictors of opioid and benzodiazepine use were a longer MV duration, assessment scales, physical restraints, and university-affiliated hospital. Although more than 50% of ICUs reported that assessment tools, protocols, and daily sedation interruption (DSI) were available for use, application was modest: sedation scale 53.0%, pain scale 19.1%, delirium scale 5.2%, protocol 25.0%, DSI 42.1%. Accidental device removal occurred in 4.6% of patients, with 75.8% of events during DSI. Daily sedation interruption was associated with protocol use, physical restraints, university-affiliated hospital, and short-duration MV. Variables associated with protocol use included assessment scales, longer MV duration, lack of physical restraints, and admission to a community hospital.ConclusionNearly all MV patients received analgo-sedation. Opioids were used more often than sedatives despite infrequent use of pain scales. Few patients received antipsychotic therapy, but physical restraint was common. Protocol use was poor compared to DSI. Duration of MV predicted the use of either. More... »

PAGES

619-630

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12630-014-0174-1

DOI

http://dx.doi.org/10.1007/s12630-014-0174-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1023290979

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24788564


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Analgesics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Analgesics, Opioid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antipsychotic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Canada", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Critical Illness", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypnotics and Sedatives", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Intensive Care Units", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neuromuscular Blocking Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Respiration, Artificial", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Restraint, Physical", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pharmacy, Mount Sinai Hospital, University of Toronto, Rm. #18-366, 600 University Ave, M5G 1X5, Toronto, ON, Canada", 
          "id": "http://www.grid.ac/institutes/grid.416166.2", 
          "name": [
            "Department of Pharmacy, Mount Sinai Hospital, University of Toronto, Rm. #18-366, 600 University Ave, M5G 1X5, Toronto, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Burry", 
        "givenName": "Lisa D.", 
        "id": "sg:person.01362024562.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362024562.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Faculty of Pharmacy, H\u00f4pital du Sacr\u00e9-Coeur, Universit\u00e9 de Montr\u00e9al, Montreal, QC, Canada", 
          "id": "http://www.grid.ac/institutes/grid.14848.31", 
          "name": [
            "Faculty of Pharmacy, H\u00f4pital du Sacr\u00e9-Coeur, Universit\u00e9 de Montr\u00e9al, Montreal, QC, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Williamson", 
        "givenName": "David R.", 
        "id": "sg:person.01365714423.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365714423.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "McGill University Health Center, and Faculty of Pharmacy, Universit\u00e9 de Montr\u00e9al, Montreal, QC, Canada", 
          "id": "http://www.grid.ac/institutes/grid.14848.31", 
          "name": [
            "McGill University Health Center, and Faculty of Pharmacy, Universit\u00e9 de Montr\u00e9al, Montreal, QC, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Perreault", 
        "givenName": "Marc M.", 
        "id": "sg:person.0772060673.93", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772060673.93"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, ON, Canada", 
          "id": "http://www.grid.ac/institutes/grid.17063.33", 
          "name": [
            "Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rose", 
        "givenName": "Louise", 
        "id": "sg:person.0740410436.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740410436.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Departments of Medicine, Clinical Epidemiology & Biostatistics, St Joseph\u2019s Healthcare, McMaster University, Hamilton, ON, Canada", 
          "id": "http://www.grid.ac/institutes/grid.25073.33", 
          "name": [
            "Departments of Medicine, Clinical Epidemiology & Biostatistics, St Joseph\u2019s Healthcare, McMaster University, Hamilton, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cook", 
        "givenName": "Deborah J.", 
        "id": "sg:person.01372124736.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372124736.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Interdepartmental Division of Critical Care Medicine, and Division of Respirology, Department of Medicine, University Health Network & Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada", 
          "id": "http://www.grid.ac/institutes/grid.17063.33", 
          "name": [
            "Interdepartmental Division of Critical Care Medicine, and Division of Respirology, Department of Medicine, University Health Network & Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ferguson", 
        "givenName": "Niall D.", 
        "id": "sg:person.0673455705.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673455705.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Toronto, Toronto, ON, Canada", 
          "id": "http://www.grid.ac/institutes/grid.17063.33", 
          "name": [
            "University of Toronto, Toronto, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lapinsky", 
        "givenName": "Stephanie C.", 
        "id": "sg:person.01142132022.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142132022.58"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada", 
          "id": "http://www.grid.ac/institutes/grid.416166.2", 
          "name": [
            "Department of Medicine, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mehta", 
        "givenName": "Sangheeta", 
        "id": "sg:person.015727671216.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015727671216.24"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/cc3495", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004395804", 
          "https://doi.org/10.1186/cc3495"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00134-006-0214-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008635299", 
          "https://doi.org/10.1007/s00134-006-0214-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s001340100909", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027303695", 
          "https://doi.org/10.1007/s001340100909"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-05-01", 
    "datePublishedReg": "2014-05-01", 
    "description": "PurposeOur aim was to describe analgo-sedation and antipsychotic and neuromuscular blocking drug (NMBD) use in critically ill patients, management strategies, and variables associated with these practice patterns.MethodsThis prospective observational study in 51 intensive care units (ICUs) included all patients who underwent invasive mechanical ventilation (MV) over a two-week period during 2008-2009.ResultsWe included 712 patients representing 3,620 patient-days. Median MV duration was 3.0\u00a0days (interquartile range 2-6). During MV, 92% of patients received analgo-sedation, 32% an adjunct agent (e.g., acetaminophen), 18% NMBDs, and 10% antipsychotics. Opioids were used more frequently than benzodiazepines or propofol (84.8% vs 62.2% vs 10.1% patients, respectively, P\u00a0<\u00a00.0001). Independent predictors of opioid and benzodiazepine use were a longer MV duration, assessment scales, physical restraints, and university-affiliated hospital. Although more than 50% of ICUs reported that assessment tools, protocols, and daily sedation interruption (DSI) were available for use, application was modest: sedation scale 53.0%, pain scale 19.1%, delirium scale 5.2%, protocol 25.0%, DSI 42.1%. Accidental device removal occurred in 4.6% of patients, with 75.8% of events during DSI. Daily sedation interruption was associated with protocol use, physical restraints, university-affiliated hospital, and short-duration MV. Variables associated with protocol use included assessment scales, longer MV duration, lack of physical restraints, and admission to a community hospital.ConclusionNearly all MV patients received analgo-sedation. Opioids were used more often than sedatives despite infrequent use of pain scales. Few patients received antipsychotic therapy, but physical restraint was common. Protocol use was poor compared to DSI. Duration of MV predicted the use of either.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s12630-014-0174-1", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1017152", 
        "issn": [
          "0832-610X", 
          "1496-8975"
        ], 
        "name": "Journal canadien d'anesth\u00e9sie", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "61"
      }
    ], 
    "keywords": [
      "daily sedation interruption", 
      "intensive care unit", 
      "longer MV duration", 
      "university-affiliated hospital", 
      "mechanical ventilation", 
      "MV duration", 
      "physical restraint", 
      "sedation interruption", 
      "care unit", 
      "protocol use", 
      "observational study", 
      "neuromuscular blocking drug (NMBD) use", 
      "MethodsThis prospective observational study", 
      "duration of MV", 
      "Assessment Scale", 
      "Canadian intensive care units", 
      "median MV duration", 
      "accidental device removal", 
      "neuromuscular blocker use", 
      "invasive mechanical ventilation", 
      "prospective observational study", 
      "blocker use", 
      "ill patients", 
      "independent predictors", 
      "MV patients", 
      "pain scale", 
      "antipsychotic therapy", 
      "benzodiazepine use", 
      "practice patterns", 
      "adjunct agent", 
      "community hospital", 
      "PurposeOur aim", 
      "patients", 
      "device removal", 
      "drug use", 
      "opioids", 
      "hospital", 
      "two-week period", 
      "infrequent use", 
      "duration", 
      "assessment tool", 
      "multicentre", 
      "delirium", 
      "antipsychotics", 
      "pain", 
      "propofol", 
      "admission", 
      "sedatives", 
      "therapy", 
      "benzodiazepines", 
      "ventilation", 
      "interruption", 
      "NMBD", 
      "restraint", 
      "predictors", 
      "study", 
      "use", 
      "management strategies", 
      "days", 
      "aim", 
      "agents", 
      "period", 
      "scale", 
      "variables", 
      "protocol", 
      "units", 
      "events", 
      "lack", 
      "patterns", 
      "strategies", 
      "removal", 
      "tool", 
      "applications"
    ], 
    "name": "Analgesic, sedative, antipsychotic, and neuromuscular blocker use in Canadian intensive care units: a prospective, multicentre, observational study", 
    "pagination": "619-630", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1023290979"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12630-014-0174-1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24788564"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12630-014-0174-1", 
      "https://app.dimensions.ai/details/publication/pub.1023290979"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-08-04T17:01", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_631.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s12630-014-0174-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12630-014-0174-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12630-014-0174-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12630-014-0174-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12630-014-0174-1'


 

This table displays all metadata directly associated to this object as RDF triples.

280 TRIPLES      21 PREDICATES      118 URIs      107 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12630-014-0174-1 schema:about N04520c9e02654aaea0bd0f9a7b322fee
2 N2fbe1854ba5742edb9075709e328bc9a
3 N41400a458e03441e8565d1a5f7fc8064
4 N46245d305d1d4cf8bb6dfbf37dd65a5a
5 N48019250e75647baae25fab9f0cff923
6 N55b60d5b1c564d9b8840c50ce2fa2b18
7 N6d4d4cbcc7274324af7b1a8e62a8cedc
8 N6f7b809413b34dfc9ba8b4b2de888c2e
9 N72a0f0a6b70549b491c7480d3bd2e28d
10 N7b61c9b69c7c45e3a86ef8eb1e3755f3
11 N83deaf7cd1da4cd58aab5fc237a66953
12 Nb1ab82cfb0724c3299fc9c0f0995ea72
13 Nb28077c21afc4175833eacae3e96cb91
14 Nd16da4fa2b234d109301db3a369f910f
15 Nd305cdea8b404ffc8d80761330168eb6
16 Nd311fe8b0de243f9ae64d50b8b19254c
17 Nfef46fadece24393ad033db5fb155fa9
18 anzsrc-for:11
19 anzsrc-for:1103
20 schema:author N4d3a19df99ac4a559cbcc15badf86e46
21 schema:citation sg:pub.10.1007/s00134-006-0214-6
22 sg:pub.10.1007/s001340100909
23 sg:pub.10.1186/cc3495
24 schema:datePublished 2014-05-01
25 schema:datePublishedReg 2014-05-01
26 schema:description PurposeOur aim was to describe analgo-sedation and antipsychotic and neuromuscular blocking drug (NMBD) use in critically ill patients, management strategies, and variables associated with these practice patterns.MethodsThis prospective observational study in 51 intensive care units (ICUs) included all patients who underwent invasive mechanical ventilation (MV) over a two-week period during 2008-2009.ResultsWe included 712 patients representing 3,620 patient-days. Median MV duration was 3.0 days (interquartile range 2-6). During MV, 92% of patients received analgo-sedation, 32% an adjunct agent (e.g., acetaminophen), 18% NMBDs, and 10% antipsychotics. Opioids were used more frequently than benzodiazepines or propofol (84.8% vs 62.2% vs 10.1% patients, respectively, P < 0.0001). Independent predictors of opioid and benzodiazepine use were a longer MV duration, assessment scales, physical restraints, and university-affiliated hospital. Although more than 50% of ICUs reported that assessment tools, protocols, and daily sedation interruption (DSI) were available for use, application was modest: sedation scale 53.0%, pain scale 19.1%, delirium scale 5.2%, protocol 25.0%, DSI 42.1%. Accidental device removal occurred in 4.6% of patients, with 75.8% of events during DSI. Daily sedation interruption was associated with protocol use, physical restraints, university-affiliated hospital, and short-duration MV. Variables associated with protocol use included assessment scales, longer MV duration, lack of physical restraints, and admission to a community hospital.ConclusionNearly all MV patients received analgo-sedation. Opioids were used more often than sedatives despite infrequent use of pain scales. Few patients received antipsychotic therapy, but physical restraint was common. Protocol use was poor compared to DSI. Duration of MV predicted the use of either.
27 schema:genre article
28 schema:isAccessibleForFree false
29 schema:isPartOf Na25b095c8161465a8a01d4a31e94d2d5
30 Nf463152fe1474243a092bfc42ecf323c
31 sg:journal.1017152
32 schema:keywords Assessment Scale
33 Canadian intensive care units
34 MV duration
35 MV patients
36 MethodsThis prospective observational study
37 NMBD
38 PurposeOur aim
39 accidental device removal
40 adjunct agent
41 admission
42 agents
43 aim
44 antipsychotic therapy
45 antipsychotics
46 applications
47 assessment tool
48 benzodiazepine use
49 benzodiazepines
50 blocker use
51 care unit
52 community hospital
53 daily sedation interruption
54 days
55 delirium
56 device removal
57 drug use
58 duration
59 duration of MV
60 events
61 hospital
62 ill patients
63 independent predictors
64 infrequent use
65 intensive care unit
66 interruption
67 invasive mechanical ventilation
68 lack
69 longer MV duration
70 management strategies
71 mechanical ventilation
72 median MV duration
73 multicentre
74 neuromuscular blocker use
75 neuromuscular blocking drug (NMBD) use
76 observational study
77 opioids
78 pain
79 pain scale
80 patients
81 patterns
82 period
83 physical restraint
84 practice patterns
85 predictors
86 propofol
87 prospective observational study
88 protocol
89 protocol use
90 removal
91 restraint
92 scale
93 sedation interruption
94 sedatives
95 strategies
96 study
97 therapy
98 tool
99 two-week period
100 units
101 university-affiliated hospital
102 use
103 variables
104 ventilation
105 schema:name Analgesic, sedative, antipsychotic, and neuromuscular blocker use in Canadian intensive care units: a prospective, multicentre, observational study
106 schema:pagination 619-630
107 schema:productId N2986e08639364e7284c0c7c3a2410597
108 Nab5996811f1742c89dfcfc8c22004bcf
109 Nef26c2446ff9447d8bab1c119fecbece
110 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023290979
111 https://doi.org/10.1007/s12630-014-0174-1
112 schema:sdDatePublished 2022-08-04T17:01
113 schema:sdLicense https://scigraph.springernature.com/explorer/license/
114 schema:sdPublisher N9ede6f2060d042038ab0832f1b36e0b0
115 schema:url https://doi.org/10.1007/s12630-014-0174-1
116 sgo:license sg:explorer/license/
117 sgo:sdDataset articles
118 rdf:type schema:ScholarlyArticle
119 N04520c9e02654aaea0bd0f9a7b322fee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Humans
121 rdf:type schema:DefinedTerm
122 N1c04640d49f64ed6b566fc8a20b65ad5 rdf:first sg:person.0740410436.86
123 rdf:rest N9cea5aa50905495884050586ddd4de00
124 N2986e08639364e7284c0c7c3a2410597 schema:name dimensions_id
125 schema:value pub.1023290979
126 rdf:type schema:PropertyValue
127 N2fbe1854ba5742edb9075709e328bc9a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Analgesics
129 rdf:type schema:DefinedTerm
130 N41400a458e03441e8565d1a5f7fc8064 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Hypnotics and Sedatives
132 rdf:type schema:DefinedTerm
133 N46245d305d1d4cf8bb6dfbf37dd65a5a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Male
135 rdf:type schema:DefinedTerm
136 N48019250e75647baae25fab9f0cff923 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Neuromuscular Blocking Agents
138 rdf:type schema:DefinedTerm
139 N4d3a19df99ac4a559cbcc15badf86e46 rdf:first sg:person.01362024562.00
140 rdf:rest N82ece618d9074bc8ac6116941c996b61
141 N55b60d5b1c564d9b8840c50ce2fa2b18 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Critical Illness
143 rdf:type schema:DefinedTerm
144 N56a59a72ed874483afb215af265fbad8 rdf:first sg:person.01142132022.58
145 rdf:rest N9cf6e41cef4947d2bc58242223f4ec46
146 N6d4d4cbcc7274324af7b1a8e62a8cedc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Middle Aged
148 rdf:type schema:DefinedTerm
149 N6f7b809413b34dfc9ba8b4b2de888c2e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Aged
151 rdf:type schema:DefinedTerm
152 N72a0f0a6b70549b491c7480d3bd2e28d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Restraint, Physical
154 rdf:type schema:DefinedTerm
155 N7b61c9b69c7c45e3a86ef8eb1e3755f3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Analgesics, Opioid
157 rdf:type schema:DefinedTerm
158 N82ece618d9074bc8ac6116941c996b61 rdf:first sg:person.01365714423.46
159 rdf:rest N99d20abb7bf9464f96720de811a9ad86
160 N83deaf7cd1da4cd58aab5fc237a66953 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Canada
162 rdf:type schema:DefinedTerm
163 N99d20abb7bf9464f96720de811a9ad86 rdf:first sg:person.0772060673.93
164 rdf:rest N1c04640d49f64ed6b566fc8a20b65ad5
165 N9cea5aa50905495884050586ddd4de00 rdf:first sg:person.01372124736.59
166 rdf:rest Naff00c9932de4e1491e1421b83c1516a
167 N9cf6e41cef4947d2bc58242223f4ec46 rdf:first sg:person.015727671216.24
168 rdf:rest rdf:nil
169 N9ede6f2060d042038ab0832f1b36e0b0 schema:name Springer Nature - SN SciGraph project
170 rdf:type schema:Organization
171 Na25b095c8161465a8a01d4a31e94d2d5 schema:issueNumber 7
172 rdf:type schema:PublicationIssue
173 Nab5996811f1742c89dfcfc8c22004bcf schema:name doi
174 schema:value 10.1007/s12630-014-0174-1
175 rdf:type schema:PropertyValue
176 Naff00c9932de4e1491e1421b83c1516a rdf:first sg:person.0673455705.49
177 rdf:rest N56a59a72ed874483afb215af265fbad8
178 Nb1ab82cfb0724c3299fc9c0f0995ea72 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Antipsychotic Agents
180 rdf:type schema:DefinedTerm
181 Nb28077c21afc4175833eacae3e96cb91 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Adult
183 rdf:type schema:DefinedTerm
184 Nd16da4fa2b234d109301db3a369f910f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Intensive Care Units
186 rdf:type schema:DefinedTerm
187 Nd305cdea8b404ffc8d80761330168eb6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Prospective Studies
189 rdf:type schema:DefinedTerm
190 Nd311fe8b0de243f9ae64d50b8b19254c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Respiration, Artificial
192 rdf:type schema:DefinedTerm
193 Nef26c2446ff9447d8bab1c119fecbece schema:name pubmed_id
194 schema:value 24788564
195 rdf:type schema:PropertyValue
196 Nf463152fe1474243a092bfc42ecf323c schema:volumeNumber 61
197 rdf:type schema:PublicationVolume
198 Nfef46fadece24393ad033db5fb155fa9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
199 schema:name Female
200 rdf:type schema:DefinedTerm
201 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
202 schema:name Medical and Health Sciences
203 rdf:type schema:DefinedTerm
204 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
205 schema:name Clinical Sciences
206 rdf:type schema:DefinedTerm
207 sg:journal.1017152 schema:issn 0832-610X
208 1496-8975
209 schema:name Journal canadien d'anesthésie
210 schema:publisher Springer Nature
211 rdf:type schema:Periodical
212 sg:person.01142132022.58 schema:affiliation grid-institutes:grid.17063.33
213 schema:familyName Lapinsky
214 schema:givenName Stephanie C.
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142132022.58
216 rdf:type schema:Person
217 sg:person.01362024562.00 schema:affiliation grid-institutes:grid.416166.2
218 schema:familyName Burry
219 schema:givenName Lisa D.
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362024562.00
221 rdf:type schema:Person
222 sg:person.01365714423.46 schema:affiliation grid-institutes:grid.14848.31
223 schema:familyName Williamson
224 schema:givenName David R.
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365714423.46
226 rdf:type schema:Person
227 sg:person.01372124736.59 schema:affiliation grid-institutes:grid.25073.33
228 schema:familyName Cook
229 schema:givenName Deborah J.
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372124736.59
231 rdf:type schema:Person
232 sg:person.015727671216.24 schema:affiliation grid-institutes:grid.416166.2
233 schema:familyName Mehta
234 schema:givenName Sangheeta
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015727671216.24
236 rdf:type schema:Person
237 sg:person.0673455705.49 schema:affiliation grid-institutes:grid.17063.33
238 schema:familyName Ferguson
239 schema:givenName Niall D.
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673455705.49
241 rdf:type schema:Person
242 sg:person.0740410436.86 schema:affiliation grid-institutes:grid.17063.33
243 schema:familyName Rose
244 schema:givenName Louise
245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740410436.86
246 rdf:type schema:Person
247 sg:person.0772060673.93 schema:affiliation grid-institutes:grid.14848.31
248 schema:familyName Perreault
249 schema:givenName Marc M.
250 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772060673.93
251 rdf:type schema:Person
252 sg:pub.10.1007/s00134-006-0214-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008635299
253 https://doi.org/10.1007/s00134-006-0214-6
254 rdf:type schema:CreativeWork
255 sg:pub.10.1007/s001340100909 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027303695
256 https://doi.org/10.1007/s001340100909
257 rdf:type schema:CreativeWork
258 sg:pub.10.1186/cc3495 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004395804
259 https://doi.org/10.1186/cc3495
260 rdf:type schema:CreativeWork
261 grid-institutes:grid.14848.31 schema:alternateName Faculty of Pharmacy, Hôpital du Sacré-Coeur, Université de Montréal, Montreal, QC, Canada
262 McGill University Health Center, and Faculty of Pharmacy, Université de Montréal, Montreal, QC, Canada
263 schema:name Faculty of Pharmacy, Hôpital du Sacré-Coeur, Université de Montréal, Montreal, QC, Canada
264 McGill University Health Center, and Faculty of Pharmacy, Université de Montréal, Montreal, QC, Canada
265 rdf:type schema:Organization
266 grid-institutes:grid.17063.33 schema:alternateName Interdepartmental Division of Critical Care Medicine, and Division of Respirology, Department of Medicine, University Health Network & Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada
267 Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, ON, Canada
268 University of Toronto, Toronto, ON, Canada
269 schema:name Interdepartmental Division of Critical Care Medicine, and Division of Respirology, Department of Medicine, University Health Network & Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada
270 Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, ON, Canada
271 University of Toronto, Toronto, ON, Canada
272 rdf:type schema:Organization
273 grid-institutes:grid.25073.33 schema:alternateName Departments of Medicine, Clinical Epidemiology & Biostatistics, St Joseph’s Healthcare, McMaster University, Hamilton, ON, Canada
274 schema:name Departments of Medicine, Clinical Epidemiology & Biostatistics, St Joseph’s Healthcare, McMaster University, Hamilton, ON, Canada
275 rdf:type schema:Organization
276 grid-institutes:grid.416166.2 schema:alternateName Department of Medicine, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada
277 Department of Pharmacy, Mount Sinai Hospital, University of Toronto, Rm. #18-366, 600 University Ave, M5G 1X5, Toronto, ON, Canada
278 schema:name Department of Medicine, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada
279 Department of Pharmacy, Mount Sinai Hospital, University of Toronto, Rm. #18-366, 600 University Ave, M5G 1X5, Toronto, ON, Canada
280 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...